Build
We design, staff and stand up the complete unit. The named-account data, the messaging, the outbound engine, the automation and the reporting.
PREPARED FOR UPM PHARMACEUTICALS
The pharma and biotech teams choosing a manufacturer, reached between the shows.
Frank, you mentioned checking back in early December. This page shows how outreach works for UPM Pharmaceuticals in the meantime, starting with the companies that need a development and manufacturing partner.
Tim Rath of Innovative Radiology on working with us
Proof, in the field
Numbers from live campaigns, not projections.
$10M+
New business sold for clients.
Sourceenquirerconsulting.com home page
3,500+
Qualified conversations generated.
Sourceenquirerconsulting.com home page
100,000+
Decision makers reached for clients.
Sourceenquirerconsulting.com home page
New business is client-reported. Campaign figures were pulled from the live platforms on July 10, 2026. A qualified conversation is a positive or interested reply. Results vary by market and offer.
Enquirer AI helps us identify the right people and start the conversation in a much smarter way.
01What we see
A family-owned CDMO. More than 80 products to market.
- 01
UPM Pharmaceuticals develops and manufactures oral solid and semi-solid drug products, from formulation through commercial production and packaging.
- 02
The Bristol, Tennessee site runs a 475,000 square foot commercial manufacturing facility, licensed for DEA-controlled substances, with dedicated high-potency compound handling.
- 03
UPM is independent and family-owned, with more than 80 products brought to market.
- 04
Customers range from early-stage biotech startups to established Big Pharma organizations.
The companies that need a manufacturing partner have people with names who make that choice. That makes them a list you can reach.
02Where this goes
Your next client is working on a product today.
Today
We do not yet know how much of UPM's new business comes from conferences, referrals or companies that find UPM first. It is the first question on the call.
Conferences and an experienced network reach the teams who are at the show or already know UPM.
Outbound puts UPM in front of the development and supply leaders who have not met UPM yet, between the shows.
In the first weeks and months
A named list of the people who choose a development and manufacturing partner at small and mid-size pharma and biotech companies, starting with the dosage forms and capabilities UPM wants to fill first.
Short, plain messages to those people from real inboxes and real profiles, written for someone deciding where a product gets made, with the copy reviewed by a person before anything sends.
Interested replies land with your commercial team as warm conversations, with the context and a way to reach them.
After four months UPM keeps the list, the domains, the mailboxes and the playbook, with a person on your team we have trained. Then we leave.
03How the engagement works
Build. Run. Own.
Run
We run it in market for a fixed four months and prove it on real booked meetings, not slides. First conversations land early.
Own
We hand over the playbook, the tooling, the dashboards and a trained operator. You own the engine.
One contractor, a network of specialists. One point of contact, and you never manage a stack of tools or freelancers.
04What we build for UPM Pharmaceuticals
How it works, in plain terms.
We set it up for UPM
We design the outreach around the companies UPM most wants to win and the people who pick a manufacturing partner. We run the list, the messaging, the sending and the reporting for a fixed four months.
People behind the engine
Research, copy, deliverability and reply handling are run by people who do this every day. Every interested reply goes to a person.
Then you own it
At handover you keep the list, the inboxes, the playbook and the dashboards. Nothing is rented back.
We empower sales teams. One point of contact, the specialists sit behind us, and you never manage a stack of tools or freelancers.
05The engine, in plain terms
Every message, written for one real person.
Target
We build the list for UPM. Named development, CMC and supply leaders at the pharma and biotech companies that need a manufacturing partner.
Personalize
AI reads each profile and writes a unique message. No templates.
Hand off warm
A positive reply pings you and your operator with the prospect and a way to reach them.
You take it from there
You take pre-qualified conversations. The engine handles everything before it.
Research-led and human-reviewed. Every message is on-brand, and most of the volume runs on capacity we operate, not only your account.
06Why we think this fits
What we test first for UPM.
Before and after each show
Outreach starts weeks ahead of the conferences you attend, so a buyer has heard of UPM before the meeting, and picks up the people you met after it.
One list per capability
Controlled substances, high-potency compounds and semi-solids each get their own list and their own message, apart from general oral solid dose work.
Lead with the track record
Messages open on what UPM has already done, more than 80 products brought to market from its Bristol facility, and the walkthrough follows.
07Next step
Yours to keep. Talk it through with Paul.
- 01
Read it when you have a few minutes. It is yours either way and nothing is owed for it.
- 02
If any of it is wrong about how UPM brings in new clients today, tell Paul and he corrects it.
- 03
Paul sends a few times as early December gets closer, the window you named, and we walk through it together.
Paul is your point of contact from here. Bring the capabilities you most want to fill and the kinds of clients you want more of, and we work through who to reach first.